Meet the Medable team

Come by booth #621 to talk with one of our clinical research and trial experts.
Chief Scientific Officer
Pamela Tenaerts
Discuss recent and current research on DCTs and current state of novel clinical trial methodologies.

Colin Weller
Discuss evidence generation, eCOA+, and the future of clinical research
VP, GM, eConsent
Andrew Mackinnon
Medable’s expert on eConsent, AI, and DCT implementation.
Chief Revenue Officer
Jason Rothbart
Discuss clinical trial technology solutions.
EGM, Digital and Decentralized Solutions
Allison Holland
Discuss your DCT and enterprise solutions.
Senior Vice President, Enterprise Sales
Tyler Pugsley
Discuss clinical trial technology solutions for large scale businesses
Business Account Leader
Deanna Coscia
Discuss clinical trial technology solutions.
Executive Director, Business Development
James Thatcher
Discuss CRO business and collaboration.

Intersection of Innovative Development Models and Investment Approaches That Move the Needle at the Portfolio Level

New to SCOPE 2024 - we bring together for the first time, a business-focused panel of strategics from the pharma, investor, healthcare, CRO, and technology start-up communities, to discuss partnership models that drive much needed innovation in clinical trials and impact development at the portfolio level. In this panel we will address the following questions:
  • How can Pharma manage risks and investments while continuing to remain at the forefront of drug development, clinical research, and trial technology?
  • What alternative business models and risk-sharing partnership can support innovation, in a resource constrained environment?
  • Where are the opportunities and the ROI from such partnerships?
  • What emerging technologies are showing growth and investment and are moving the needle in clinical research?
  • TBD
  • Tuesday, February 13
  • 3:30 PM EST
  • 30 minutes
Michelle Longmire
Co-Founder and CEO

Angela DeLuca
Vice President, Head of Oncology & Cell Therapies Clinical Operations, Global Development Office, R&D

Michael Greeley
Flare Capital Partners
Co-Founder & General Partner, Healthcare Technology

The New Frontier:
How Intelligent Automation is Transforming Clinical Deployment

Join us as Colin Weller, GM, Evidence Generation Platform at Medable, unveils how intelligent automation technology reduces clinical trial deployment timelines and accelerates evidence generation at scale as shown in their latest results to reduce trial deployment timelines by 50%. Weller will discuss how Top-10 global pharmaceutical companies are benefiting from Medable’s novel technology, and how the expanded use of digital measures and biomarkers will continue to accelerate clinical development timelines.
  • TBD
  • Tuesday, February 13
  • 8:30 AM EST
  • 30 minutes
Colin Weller
General Manager, Platform

Meet with the Medable team